ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 396 filers reported holding ENCOMPASS HEALTH CORP in Q2 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,044 | -10.7% | 90,000 | -10.0% | 3.05% | +92.9% |
| Q2 2023 | $6,769 | +127.5% | 99,976 | +81.8% | 1.58% | +23.8% |
| Q1 2023 | $2,976 | -41.5% | 55,000 | -35.3% | 1.28% | -46.5% |
| Q4 2022 | $5,084 | -99.9% | 85,000 | 0.0% | 2.39% | +11.9% |
| Q3 2022 | $3,845,000 | +5.5% | 85,000 | +30.8% | 2.14% | +3.2% |
| Q2 2022 | $3,643,000 | -37.8% | 65,000 | -21.1% | 2.07% | -14.4% |
| Q1 2022 | $5,859,000 | +199.2% | 82,392 | +174.6% | 2.42% | +188.3% |
| Q4 2021 | $1,958,000 | -73.9% | 30,000 | -70.0% | 0.84% | -53.2% |
| Q3 2021 | $7,504,000 | +37.4% | 100,000 | +42.9% | 1.79% | +68.0% |
| Q2 2021 | $5,462,000 | -25.9% | 70,000 | -22.2% | 1.07% | -60.3% |
| Q1 2021 | $7,371,000 | +98.1% | 90,000 | +100.0% | 2.69% | +77.2% |
| Q4 2020 | $3,721,000 | -11.9% | 45,000 | -30.8% | 1.52% | -16.5% |
| Q3 2020 | $4,224,000 | -45.4% | 65,000 | +100.0% | 1.82% | -40.4% |
| Q1 2020 | $7,733,000 | – | 32,500 | – | 3.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |